We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current 0QQJ market cap is 1.91M. The company's latest EPS is CHF 0.1444 and P/E is 6.23.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 7.54M | 9.88M | 15.54M | 9.44M | 0 |
| Operating Income | -24.91M | -42.03M | -40.39M | -92.24M | 789k |
| Net Income | -29.87M | -41.27M | -43.37M | -105.23M | 1.04M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 166.89M | 156.17M | 131.01M | 9.83M | 7.54M |
| Total Liabilities | 21.8M | 24.4M | 24.77M | 4.28M | 946k |
| Total Equity | 145.09M | 131.77M | 106.24M | 5.55M | 6.6M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | -23.36M | -29.79M | -18.88M | -9.26M | -2.44M |
| Investing | -5.6M | -4.64M | -1.76M | 15.95M | 3.52M |
| Financing | 8.86M | 25.72M | 14.77M | -5.97M | -163k |
| Market Cap | 1.91M |
| Price to Earnings Ratio | 6.23 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.96 |
| Price to Book Ratio | 0.99 |
| Dividend Yield | - |
| Shares Outstanding | 7.23M |
| Average Volume (1 week) | 25 |
| Average Volume (1 Month) | 205 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.264 |
| 52 Week Low | 0.264 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Evolva Holding Sa |
| Address |
duggingerstra��e 23 reinach 4153 |
| Website | https://www.evolva.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
